FDA Best Audit Practices – Get Ready For The Inspection That Is Coming
ConferencePanel1
58 views
23 slides
Jul 29, 2024
Slide 1 of 23
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
About This Presentation
2024 Best practice for FDA Audit and Inspection webinar will begin by discussing and emphasizing the importance of truthfulness to the process – truthfulness in performing the job on a daily basis, truthfulness in completing the regulatory documentation that is so much a part of our regulatory liv...
2024 Best practice for FDA Audit and Inspection webinar will begin by discussing and emphasizing the importance of truthfulness to the process – truthfulness in performing the job on a daily basis, truthfulness in completing the regulatory documentation that is so much a part of our regulatory lives, and finally in the context of this webinar, truthfulness when interacting with FDA inspectors.
A key component of this webinar is the discussion of the tricks and techniques that inspectors use to elicit information. How you react and respond when they occur could impact your results.
Other key communication skills will be presented in the context of the inspection and interpersonal exchanges between inspectors and company associates being questioned.
We will complete the webinar by discussing how to handle, in the moment, adverse findings as they are identified by the inspector so as to not compound the issues and severity of the findings.
Areas Covered
2024 Best practice for FDA Audit and Inspection Covers
Importance of truthfulness
Importance of knowledgeability and confidence
FDA Tricks to elicit information
Arguing and challenging
Behavior during the inspection
Importance and role of documentation
Effective communication skills
Being deceptive
Opinion versus fact
Phrases never to say
Handling adverse findings during the inspection
WhodoestheFDAInspect?
◼FederalFood,Drug,andCosmetics(FD&C)Act, domestic drug
establishments, and Class II and Class III device manufacturers inspected
every two years
◼Foreignmanufacturers
◼Inspections conducted based on risk
◼Higher-risk products more likely to be audited
◼Facilities having historically significant violations
◼Inspection focus
Quality and Product Safety
Facility
Process
Data
3
Pre-ApprovalInspections
7
◼FDA approves New Drug Applications, Abbreviated New
DrugApplications,BiologicLicensingApplications
◼Assure that controls for manufacture, processing,
packing,andtestingareadequate
◼Pre-approvalinspectionperformedtoensurethat
manufacturercanmanufacturethedrug.
PostInspection
13
◼If the inspection has an Official Action
Indicated classification, FDA send a
warningletter
◼Companywillneedtoreply
◼FDAconductsafollow-upinspection
◼FDAmayissueaclose-outletter